DRUG-PATHWAY

DRUGs and PATHWAYs

PATHWAY_NAME	REACTOME_ID	KEGG_ID	DRUG_NAME	PUBCHEM_CID	Datasource
Regulation of actin cytoskeleton	R-HSA-392751	map04810	digoxigenin	4826	drug-path
Cytokine-cytokine receptor interaction	R-HSA-6788467	map04060	digoxigenin	4826	drug-path
Ribosome	R-HSA-5368277	map03010	digoxigenin	4826	drug-path
Alzheimer's disease	R-HSA-1643685	0	felbinac	3332	drug-path
Huntington's disease	R-HSA-1643685	0	felbinac	3332	drug-path
Olfactory transduction	R-HSA-9751605	map04740	felbinac	3332	drug-path
Systemic lupus erythematosus	R-HSA-977105	map05322	felbinac	3332	drug-path
Cell cycle	R-HSA-1640170	map04110	felbinac	3332	drug-path
Parkinson's disease	R-HSA-1643685	0	felbinac	3332	drug-path
Ribosome	R-HSA-5368277	map03010	felbinac	3332	drug-path
Glioma	Q9NZM4	map05214	diloxanide	11367	drug-path
Olfactory transduction	R-HSA-9751605	map04740	diloxanide	11367	drug-path
Adipocytokine signaling pathway	R-HSA-168638	map04920	diloxanide	11367	drug-path
Shigellosis	0	map05131	diloxanide	11367	drug-path
Huntington's disease	R-HSA-1643685	0	diloxanide	11367	drug-path
Pathogenic Escherichia coli infection	R-HSA-9609646	map05130	diloxanide	11367	drug-path
RNA polymerase	R-HSA-73864	map03020	diloxanide	11367	drug-path
Olfactory transduction	R-HSA-9751605	map04740	2-aminobenzenesulfonamide	26098	drug-path
Systemic lupus erythematosus	R-HSA-977105	map05322	2-aminobenzenesulfonamide	26098	drug-path
Vascular smooth muscle contraction	R-HSA-445355	map04270	2-aminobenzenesulfonamide	26098	drug-path